These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 7784331)
21. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF. Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640 [TBL] [Abstract][Full Text] [Related]
23. Action of enkephalinase (EC 3.4.24.11) inhibition on the pre- and post-prandial electromyographic patterns of colon in rats. Benouali S; Berard H; Roche M Neuropeptides; 1993 May; 24(5):299-305. PubMed ID: 8392143 [TBL] [Abstract][Full Text] [Related]
24. [Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea]. Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM Ann Gastroenterol Hepatol (Paris); 1992; 28(6-7):279-85. PubMed ID: 1285638 [No Abstract] [Full Text] [Related]
33. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan. Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543 [TBL] [Abstract][Full Text] [Related]
34. Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor. Knisely JS; Beardsley PM; Aceto MD; Balster RL; Harris LS Drug Alcohol Depend; 1989 Apr; 23(2):143-51. PubMed ID: 2702924 [TBL] [Abstract][Full Text] [Related]
35. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo. Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620 [TBL] [Abstract][Full Text] [Related]
36. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550 [TBL] [Abstract][Full Text] [Related]
37. The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide. Roge J; Baumer P; Berard H; Schwartz JC; Lecomte JM Scand J Gastroenterol; 1993 Apr; 28(4):352-4. PubMed ID: 8488368 [TBL] [Abstract][Full Text] [Related]
38. Acetorphan, an enkephalinase inhibitor, decreases gastric secretion in cats. Bado A; Chicau-Chovet M; Appia F; Dubrasquet M; Lecomte JM; Rozé C Peptides; 1987; 8(1):89-93. PubMed ID: 3554169 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats. Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364 [TBL] [Abstract][Full Text] [Related]
40. New orally active enkephalinase inhibitors: their synthesis, biological activity, and analgesic properties. Senokuchi K; Nakai H; Nagao Y; Sakai Y; Katsube N; Kawamura M Bioorg Med Chem; 1998 Apr; 6(4):441-63. PubMed ID: 9597188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]